Post-Graduate Program and Department of Physiotherapy, Centro Universitário Metodista, Instituto Porto Alegre, Porto Alegre, Brazil.
Respir Care. 2012 Sep;57(9):1405-12. doi: 10.4187/respcare.01481. Epub 2012 Feb 17.
Expiratory positive airway pressure (EPAP) is a form of noninvasive positive-pressure ventilatory support that, in spite of not unloading respiratory muscles during inspiration, may reduce the inspiratory threshold load and attenuate expiratory dynamic airway compression, contributing to reduced expiratory air-flow limitation in patients with COPD. We sought to determine the effects of EPAP on operational lung volumes during exercise in COPD patients.
This was a nonrandomized, experimental comparison of 2 exercise conditions (with and without EPAP); subjects completed a treadmill exercise test and performed, before and immediately after exercise, lung volume measurements. Those who overtly developed dynamic hyperinflation (DH), as defined by at least a 15% reduction from pre-exercise inspiratory capacity (IC), were invited for an additional research visit to repeat the same exercise protocol while receiving EPAP through a spring loaded resistor face mask. The primary outcome was IC variance (pre-post exercise) comparison under the 2 exercise conditions.
Forty-six subjects (32 males), a mean 65.0 ± 8.2 years of age, and with moderate to severe COPD (FEV(1) = 38 ± 16% predicted) were initially enrolled. From this initial sample, 17 (37%) presented overt DH, as previously defined. No significant difference was found between these subjects and the rest of the initial sample. Comparing before and after exercise, there was significantly less reduction in IC observed when EPAP was used (-0.18 ± 0.35 L vs -0.57 ± 0.45 L, P = .02), allowing greater IC final values (1.45 ± 0.50 L vs 1.13 ± 0.52 L, P = .02).
The application of EPAP reduced DH, as shown by lower operational lung volumes after submaximal exercise in COPD patients who previously manifested exercise DH.
呼气末正压通气(EPAP)是一种非侵入性正压通气支持方式,尽管在吸气过程中不能为呼吸肌减负,但可降低吸气阈负荷并减轻呼气时动态气道压迫,从而减少 COPD 患者呼气时气流受限。我们旨在确定 EPAP 对 COPD 患者运动时肺功能的影响。
这是一项非随机的、实验性的对比研究,比较了 2 种运动条件(有和没有 EPAP);患者完成了跑步机运动测试,并在运动前和运动后立即进行了肺量计测量。那些明显出现动态过度充气(DH)的患者(定义为吸气量至少较运动前降低 15%)被邀请参加额外的研究访问,在接受弹簧加载电阻面罩 EPAP 的同时重复相同的运动方案。主要结局是比较两种运动条件下的吸气量变异(运动前后)。
46 名患者(32 名男性),平均年龄 65.0 ± 8.2 岁,中重度 COPD(FEV1=38 ± 16%预测值),最初入组。在初始样本中,有 17 名(37%)患者如前所述表现出明显的 DH。这些患者与初始样本其余部分之间没有显著差异。与运动前相比,使用 EPAP 时 IC 下降幅度明显更小(-0.18 ± 0.35 L 比-0.57 ± 0.45 L,P=0.02),因此 IC 最终值更大(1.45 ± 0.50 L 比 1.13 ± 0.52 L,P=0.02)。
在先前表现出运动性 DH 的 COPD 患者中,亚最大运动量后 EPAP 的应用降低了 DH,表现为更低的肺功能。